C3 and Alzheimer disease: Previous strategies to attenuate microglial phagocytic activity have shown some potential to reduce AD-associated pathology in mice, notably preventing synapse loss and rescuing cognitive deficits by complement C3 deficiency, C1qa knockout, or blocking [4,21,42].